Connection
Robert Jotte to Genotype
This is a "connection" page, showing publications Robert Jotte has written about Genotype.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.019 |
|
|
|
-
von Pawel J, Jotte R, Spigel DR, O'Brien ME, Socinski MA, Mezger J, Steins M, Bosquée L, Bubis J, Nackaerts K, Trigo JM, Clingan P, Schütte W, Lorigan P, Reck M, Domine M, Shepherd FA, Li S, Renschler MF. Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer. J Clin Oncol. 2014 Dec 10; 32(35):4012-9.
Score: 0.019